Browse > Article

Inhibitory Effect of YBR on Hepatic Fibrogenesis  

Seung, Hyun-Seok (Dept. of Internal Medicine, College of Oriental Medicine, Kyung-Hee University)
Woo, Hong-Jung (Dept. of Internal Medicine, College of Oriental Medicine, Kyung-Hee University)
Publication Information
The Journal of Internal Korean Medicine / v.31, no.2, 2010 , pp. 314-330 More about this Journal
Abstract
Objective : This study was performed to investigate the anti-fibrogenic effect and changes of inflammation-related genes by YBR I and YBR II (YBR I: Arteisiae Capillaris Herba, Atractylodis Rhizoma Alba, Hoelen/ YBR II: YBR I +Sanguisorbae Radix, Biotae Cacumen, Cirsii Japonici Herba) on HSC(hepatic stellate cells)-T6 and TAA-induced rat liver tissue. Materials and Methods : HSC-T6 were treated with various concentrations of distilled-water extract YBR I and YBR II extract for 24, 48 and 72 hours. After the treatment, cell viability, proliferation, procollagen levels and IL-6 levels were measured by using MTT Assay, BrdU Assay, Procollagen Type 1 C-peptide EIA kit, and Murine IL-6 ELISA Development kit. Rat liver fibrosis was induced by intraperitoneal TAA injection of 150mg/kg 3 times a week for 6 weeks. After the treatment, body weight, liver & spleen weights, liver function test, complete blood cell count and change of portal pressure were studied. In addition, gene expressions of ASMA, IL-6, MMP-2, TIMP-1 and TIMP-2, all of which are known to be associated with liver fibrosis, were analyzed by using Real-Time PCR. After YBR I and YBR IItreatment, percentages of collagen in TAA-induced rat liver tissue were measured. Results : The viability and proliferation of the HSC-T6 decreased as the concentration increased. The production of procollagen decreased as the concentration increased. The production of IL-6 was little influenced by YBR I and YBR II. There was no difference in rat body weight between the TAA-only group and the YBR groups. Compared with rat liver weight of TAA-only group, that of the YBR groups increased. In the YBR I group, the serum level of AST elevated by TAA injection significantly decreased and in the YBR I and II group, the serum level of ALP and ALT elevated by TAA injection decreased. In the YBR I group, white blood cell count elevated by TAA injection decreased but platelets increased. In the YBR I group, the portal pressure elevated by TAA injection significantly decreased. Decreases in the gene expression of ASMA and MMP-2 were observed in the YBR I group. The gene expression of IL-6 was little influenced by YBR I and YBR II -treated groups. In the histological finding, TAA injections caused severe fibrosis, but YBR I and YBR II treatment significantly reduced the amounts of hepatic collagens. Conclusions : These results suggest that YBR I and II have inhibitory effects on the hepatic fibrogenesis.
Keywords
Arteisiae Capillaris Herba; TAA; Hepatic Stellate Cell;
Citations & Related Records
Times Cited By KSCI : 7  (Citation Analysis)
연도 인용수 순위
1 Simile MM, Banni S, Angioni E, Carta G, De Miglio MR, Muroni MR et al. 5`-Methylthioadenosine administration prevents lipid peroxidation and fibrogenesis induced in rat liver by carbon-tetrachloride intoxication. J Hepatol. 2001;34:386-94.   DOI   ScienceOn
2 Kimura K, Ando K, Ohnishi H, Ishilawa T, Kakumu S, Takemura M, et al. Immunopathogenesis of hepatic fibrosis in chronic liver injury induced by repeatedly administered concanavalin A. Int Immunol. 1999;11:1491-500.   DOI   ScienceOn
3 Friedman SL. Liver fibrosis-from bench to beside. J Hepatol. 2003;s38-s53.
4 Williams EJ, Benyon RC, Trim N, Hadwin R, Grove BH, Arthur MJ et al. Ralaxin inhibits effective deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo. Gut. 2001;49(4):577-8.   DOI   ScienceOn
5 Muller A, Machnik F, Zimmermann T, et al. Thioacetamide-induced cirrhosis-like liver lesions in rats usefulness and reliability of this animal model. Exp Pathol. 1988;34:229-36.   DOI   ScienceOn
6 Jeong TC, Gu HK, Park JI, Yun HI, Kim HC, Ha CS et al. Pretreatment of male BALB/c mice with beta-ionone potentiates thioacetamide -induced hepatotoxicity. Toxicol Lett. 1999;105: 39-46.   DOI   ScienceOn
7 Muller A, Machnik F, Zimmermann T, Schubert H. Thioacetamide-induced cirrhosis-like liver lesions in rats unusefulness and reliability of this animal model. Exp Pathol. 1988;34:229-36.   DOI   ScienceOn
8 Jang KT, Lee MS, Jung IP, Kim MR, Jang JJ. Effect of pehtoxifylline on liver fibrosis and cell cycle related proteins in thioacetamide -induced rat cirrhosis. Korean J Hepatol. 2001; 7:281-91.
9 통계청. 2008년 사망원인통계결과.
10 전국한의과대학 간계내과학 교수 공저. 간계내과학. 서울: 동양의학연구원; 2001, p. 323-5.
11 정규원. 만성 간질환의 미세구조-간섬유조직증식과 간유동의 성상세포. 대한간학회지. 2002; 8(3):343-53.
12 Jeong DH, Jang JJ, Lee SJ, Lim IK, Lee MJ, et al. Expression patterns of cell cycle-related proteins in a rat cirrhotic model induced by CCl4 or thioacetamide. J Gastroenterol. 2001; 36:24-32.   DOI   ScienceOn
13 Jenkins SA,Grandison A, Baxter JN, Day DW, Taylor I, Shields R, A dimethylnitrosamineinduced model of cirrhosis and portal hypertension in the rat. Jouranal of Hepatology. 1985;1: 489-99.   DOI   ScienceOn
14 Xiangnong Li, Irving S. Benjamin, Barry Alexander. Reproducible production of thioacetamide-induced macronodular cirrhosis in the rat with no mortality. Journal of Hepatology. 2002;36:488-93.   DOI   ScienceOn
15 Lee SS, Girod C, Braillon A, Hadengue A, Lebrec D. Hemodynamic characterization of chronic bile duct-ligated rats: effect of pentobarbital sodium. Am J Physiol. 1986;251:G176-G80.
16 Giavarotti L, D`Almeida V, Giavarotti KA, Azzalis LA, Rodrigues L, Cravero AA, et al. Liver necrosis induced by acute intraperitoneal ethanol administration in aged rats. Free Radic Res. 2002;36:269-75.   DOI   ScienceOn
17 승현석, 김영철, 이장훈, 우홍정. 인진청간탕이 간보호 및 섬유화 억제에 미치는 영향. 대한한방내과학회지. 2003;24(1):21-32.   과학기술학회마을
18 이은, 김영철, 고흥. 生肝健脾湯加三七根이 흰 쥐의 감선유화 억제에 미치는 영향. 대한한방내과학회지. 2008;29(2):500-11.   과학기술학회마을
19 전국한의과대학 본초학교수 편저. 本草學. 영림사; 1994, p. 328, 302, 536, 392, 395, 390.
20 Friedman SL. The cellular basis of hepatic fibrosis. N Engl J Med. 1993;25:1828-35.
21 Kim KH, Bae JH, Cha SW, Han SS, Pa가 KH, Jeong TC. Role of metabolic activation by cytochrome P450 in thioacetamide-induced suppression of antibody response in male BALB/c mice. Toxicol Lett. 1999;105:39-46.   DOI   ScienceOn
22 권영오. 간섬유화 치료의 최신지견. 대한간학회 제3차 Postgraduate Course. 2005;33-9.
23 경희대학교 부속한방병원. 경희한방처방집. 서울: 트윈기획; 1997, p. 244.
24 우홍정. 만성B형간염에 대한 인진청간탕의 효과. 제2회 한중 학술대회 참가 논문집(간장병). 1995;18-53.
25 Perez Tamayo R. Is cirrhosis of the liver experimentally produced by CCl4 and adequate model of human cirrhosis? Hepatology. 1988; 3:112-20.
26 이관식, 간섬유화 기전. 대한간학회 제3차 Postgraduate Course. 2005;9-19.
27 Rockey DC. Antifibrotic therapy in chronic liver disease. Clin Gastroenterol Hepatol. 2005;3:95-107.   DOI   ScienceOn
28 최은경, 이장훈, 김영철, 우홍정. 단삼이 간성상세포의 섬유화 억제에 미치는 영향. 대한한방내과학회지. 2008;29(2):229-310.   과학기술학회마을
29 김영철, 이장훈, 우홍정. 인진청간탕이 흰쥐의 간장 비실질세포의 procollagen 합성 억제에 미치는 효과에 관한 연구. 대한한방내과학회지. 2003;24(4):817-25.
30 박상백, 김영철, 이장훈, 우홍정. 인진청간탕이 DMN 유발 간섬유화와 단백질 발현에 미치는 영향. 대한한방내과학회지. 2008;29(1):200-18.   과학기술학회마을
31 김성아, 우홍정, 김영철, 이장훈. 인진이 간성상세포의 섬유화 억제에 미치는 영향. 대한한방내과학회지. 2008;29(1):177-88.   과학기술학회마을
32 Yoshiji H, Noguchi R, Kuriyama S, Ikenaka Y, Yoshii J, Yanase K et al. Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats. Am J Physiol. 2005;288(5):907-13.
33 박신명, 김영철, 이장훈, 우홍정. TAA로 유발된 간섬유화 동물 모델에서 인진청간탕의 효과. 대한한방내과학회지. 2009;30(2):270-87.   과학기술학회마을